Interventional Study of Videoconferences Between Hospital and Municipality - a Randomized Controlled Trial

NCT02303249 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1387

Last updated 2015-01-12

No results posted yet for this study

Summary

The study aims to assess whether the review of discharge planning followed by a cross-sectoral video conference in connection with discharge of medical and geriatric patients at Roskilde and Køge hospitals as well as patients from the Emergency Department at Køge Hospital reduces the proportion of patients who are readmitted within 180 days.

Project nurses at the two hospitals identifies all patients fulfilling the inclusion criteria (above 55 years of age, discharged to their own home), get informed consent and performs the video conferences. Within a few hours after discharge a video conference is held in the patient´s home including the patient,the municipal nurse and the project nurse at the hospital. During the video conference the discharge is reviewed using a structured assessment.

The survey is conducted as an open, randomized intervention study.

Conditions

  • Discharge Planning
  • Readmission, Hospital

Interventions

OTHER

Review of discharges and cross-sectoral video conferencing immediately after discharge

The intervention is video conference which is randomized and is an intervention that is assigned by the investigator.

Sponsors & Collaborators

  • Region Zealand

    collaborator OTHER
  • Roskilde Municipality

    collaborator UNKNOWN
  • Køge Municipality

    collaborator UNKNOWN
  • Stevns Municipality

    collaborator UNKNOWN
  • Solrød Municipality

    collaborator UNKNOWN
  • Lejre Municipality

    collaborator UNKNOWN
  • Faxe Municipality

    collaborator UNKNOWN
  • Greve Municipality

    collaborator UNKNOWN
  • Zealand University Hospital

    lead OTHER

Principal Investigators

  • Solvejg Henneberg Pedersen, dr. · Region Zealand

  • Birgitte Dreyer Sørensen, cand. scient. san. publ. · Region Zealand

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2014-12-31
Completion
2015-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02303249 on ClinicalTrials.gov